LexaGene Holdings Inc. (LXXGF) Research

LexaGene Holdings Inc. is a biotechnology firm dedicated to the innovation, development, and market release of systems designed for identifying pathogens. Its core offering is MiQLab, an automated pathogen detection platform poised to revolutionize how pathogens are detected in diverse fields, including veterinary and human clinical diagnostics, food and water safety analysis, and other life science applications. This cutting-edge system can be deployed directly where samples are collected, providing exceptional user-friendliness, precise sensitivity, and a broad scope for pathogen identification. The company was established in 2007 and operates from its headquarters in Beverly, Massachusetts.

Market snapshot

Symbol
LXXGF
Price
$0.08
Day change
0.00%
Market cap
$27.6M
P/E ratio
-2.60x
52-week range
0.04963-0.2213
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Antibe Therapeutics Inc. (ATBPF)
  • Avecho Biotechnology Limited (AVEFF)
  • Cloud DX Inc. (CDXFF)
  • RIV Capital Inc. (CNPOF)
  • Eiger BioPharmaceuticals, Inc. (EIGRQ)
  • Living Cell Technologies Limited (LVCLY)
  • MGC Pharmaceuticals Limited (MGCLF)
  • Progressive Care, Inc. (RXMD)

Open LexaGene Holdings Inc. (LXXGF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.